PB MEDIC
ActivePB MEDIC has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €193k and a net result of €91k. Its solvency ranks better than 95% of 19909 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2024
93
/ 100
Excellent= vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth52
Stability94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days acceptable
Liquidity ample (current ratio 61.39 against 20.33 in 2023), and 1.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
98.5%
Return on assets
46.4%
Age of the figures
20 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-06-2025, 33 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
not confirmed
2024
33 d early
2023
37 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€193k▲ 88.9%
2023 · €102k
2023: €102k
2023 → 2024
Total assets
€196k▲ 83.9%
2023 · €107k
2023: €107k
2023 → 2024
Net result
€91k▼ 6.5%
2023 · €97k
2023: €97k
2023 → 2024
Working capital
€175k▲ 107%
2023 · €85k
2023: €85k
2023 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20232024Trend
Equity€102k-€193k▲ 88.9%
Operating result€131k-€117k▼ 11.1%
Net result€97k-€91k▼ 6.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 11% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €196k
Fixed assets
€18k▲ 2.4%
Current assets
€178k▲ 100%
Equity and liabilities €196k
Equity
€193k▲ 88.9%
Debt
€3k▼ 33.7%
The debt ratio falls from 4.1% to 1.5%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€118k▼
2023 · €132k
Cash flow
€92k▼
2023 · €98k
Solvency
98.5%▲
2023 · 95.9%
Current ratio
61.39▲
2023 · 20.33
Quick ratio
61.39▲
2023 · 20.33
Debt / equity
0.02▼
2023 · 0.04
ROE
47.1%▼
2023 · 95.1%
ROA
46.4%▼
2023 · 91.2%
Interest coverage
70.66▼
2023 · 356.06
Debt
€3k▼
2023 · €4k
Debt ≤ 1 year
€3k▼
2023 · €4k
Income taxes
€25k▼
2023 · €34k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€107k€196k▲
Fixed assets21/28€18k€18k▲
Tangible fixed assets22/27€3k€4k▲
Furniture and vehicles24€3k€4k▲
Financial fixed assets28€15k€15k=
Current assets29/58€89k€178k▲
Amounts receivable within one year40/41€2k€33k▲
Trade receivables40€2k€2k▲
Other amounts receivable41€374€30k▲
Current investments50/53-€21k
Cash at bank and in hand54/58€84k€122k▲
Deferred charges and accrued income490/1€3k€2k▼
Equity and liabilities
Total equity and liabilities10/49€107k€196k▲
Equity10/15€102k€193k▲
Contributions10/11€5k€5k=
Reserves13€50k€50k=
Non-distributable reserves130/1€50k-
Reserves not available under the articles1311€50k-
Distributable reserves133-€50k
Profit (loss) carried forward14€47k€138k▲
Amounts payable17/49€4k€3k▼
Amounts payable within one year42/48€4k€3k▼
Trade debts44€389€397▲
Suppliers440/4€389€397▲
Taxes, remuneration and social security45€4k€3k▼
Taxes450/3€4k€3k▼
Other amounts payable47/48€150-
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€2k▲
Other operating charges640/8€1k€694▼
Gross operating margin9900€134k€119k▼
Operating profit (loss)9901€131k€117k▼
Financial income75/76B€5€212▲
Recurring financial income75€5€212▲
Financial charges65/66B€372€2k▲
Recurring financial charges65€372€2k▲
Profit (loss) for the period before taxes9903€131k€115k▼
Income taxes67/77€34k€25k▼
Profit (loss) for the period9904€97k€91k▼
Profit (loss) for the period to be appropriated9905€97k€91k▼
Appropriation of the result
Profit (loss) to be appropriated9906€97k€138k▲
Profit (loss) brought forward from the previous period14P-€47k
Transfer to equity691/2€50k-
To other reserves6921€50k-
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
28-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity triplescurrent ratio 61.39
Current ratio from 20.33 to 61.39; short-term debt falls from €4k to €3k.
31-12
Financial
Equity above €150kEq €193k ▲88.9%
2 profitable years in a row build equity to €193k.
24-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gerpinnes · 2 establishment units since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Avenue Fabiola(GER) 16280 GerpinnesGround area
2,222 m²
Building footprint
245 m²
Volume, LiDAR
690 m³
2 parcels, Wallonia · tallest building 7.4 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
PB MEDIC
since 20222.331.286.617
PB MEDIC
since 20222.331.286.716
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52025B0321/00L003 | Wallonia | 1,193 m² | 1 · 119 m² | 7.4 m · 2 fl. |
| 92013H0326/00C002 | Wallonia | 1,029 m² | 1 · 126 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
984500CF6981A36D4A79
Similar companies · same sector, comparable size
Dokter Dessers Nathalie
BE 0789.352.445
Sint-Truiden · Eq €193k
Huisartspraktijk Van der Wilt
BE 0836.109.316
Mechelen · Eq €193k
Dokterspraktijk Pascal Kwanten
BE 0713.750.645
Westerlo · Eq €193k
Dokter Mohamed Ghazal
BE 0765.356.130
Antwerpen · Eq €193k
CABINET DOCTEUR STEPHANIE ANDRIS, Médecine générale
BE 0533.983.911
Walcourt · Eq €193k
Of 9,103 companies in sector 86210 we hold annual accounts for 6,324. 5,402 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded10-05-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.